2018. STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS. International Research Journal of Pharmacy. 9, 8 (Aug. 2018), 125–128. DOI:https://doi.org/10.56802/gzfvmr94.